The Business of Health with Chip Kahn
July 21, 2026
Video
About this Episode
Episode 13, AI Series: AI is racing into everyday medicine. The rules of the road are still being written. Dr. Michelle Mello of Stanford, professor at both the Law School and the School of Medicine, and co-leader of its Healthcare Ethical Assessment Lab for AI, joins Chip to address the questions that trail every advance this series has covered: who makes the rules, who ensures the technology gets it right — and who answers when it doesn’t?
The Host
Charles N. Kahn III is a senior visiting fellow at KFF. He is also a visiting senior fellow at the American Enterprise Institute and a nonresident senior scholar at the University of Southern California’s Schaeffer Center for Health Policy & Economics. He serves as co-chair of the international Future of Health collaborative.
Guest
Michelle Mello, JD, Ph.D.
Professor of Law, Stanford Law School; Professor of Health Policy, Stanford University School of Medicine
Michelle Mello is a Professor of Law at Stanford Law School and Professor of Health Policy at Stanford University School of Medicine. She conducts empirical research into issues at the intersection of law, ethics, and health policy. She is the author of nearly 300 articles on artificial intelligence, medical liability and patient safety, ethical and legal issues arising in biomedical research, and other topics. She is co-director of the Healthcare Ethical Assessment Lab for Artificial Intelligence (HEAL-AI) at Stanford University, which conducts ethical assessments of AI tools proposed for deployment at Stanford Health Care facilities. Mello holds a Ph.D. in Health Policy and Administration in addition to a law degree.
SERIES
This weekly podcast features insightful conversations between host Chip Kahn and his guests, who discuss the business of health care, connecting the dots between the health care business, policy, and patients.
The podcast’s first series on AI in health care illuminates how AI is changing health care, and features guests who are deploying this technology, managing its consequences, and designing policy around it.
Other Health,Artificial Intelligence,Delivery System,Food and Drug Administration (FDA),Health and Human Services (HHS),Health I.T.,Health System Performance,Health Workforce,Hospitals,Medical Technology,Physicians,TreatmentArtificial Intelligence,Delivery System,Food and Drug Administration (FDA),Health and Human Services (HHS),Health I.T.,Health System Performance,Health Workforce,Hospitals,Medical Technology,Physicians,Treatment#Guardrails #Health #Care #High1784625876
